Like this article?
Get your free daily medical news from Physician's First Watch.
FDA Updates Pancreatitis Warning on Diabetes Drug
The FDA is alerting physicians to six reports of hemorrhagic or necrotizing pancreatitis in patients using the diabetes drug exenatide (Byetta). Two of those patients died.
In October 2007, the agency first warned physicians of a possible link between exenatide and acute pancreatitis, but there were no reports of hemorrhagic or necrotizing pancreatitis at that time.
The FDA says patients should not be given exenatide if pancreatitis is suspected. In addition, the drug should not be restarted after treatment for confirmed pancreatitis.
LINK(S):
FDA alert (Free)
Associated Press story (Free)
Physician's First Watch coverage of original FDA warning (Free)
Published in Physician's First Watch August 19, 2008
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.